Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCs

BACKGROUND: The lower sales price of generic lamivudine has caused healthcare administrators to consider abolishing fixed-dose antiretroviral combinations (FDCs) that contain lamivudine and emtricitabine. The alternative is to administer the individual components of the FDCs separately, thus incorpo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Homar, Francesc, Lozano, Virginia, Martínez-Gómez, Juan, Oyagüez, Itziar, Pareja, Antonio, Payeras, Antoni, Serrano, Joaquín, Carratalá, Carmen, Casado, Miguel Ángel
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer 2012
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3484113/
https://ncbi.nlm.nih.gov/pubmed/22943676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-2-16
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak